Literature DB >> 25483549

Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain.

Luis Urbiztondo1, Sonia Broner, Josep Costa, Laura Rocamora, José M Bayas, Magda Campins, Maria Esteve, Eva Borras, Angela Domínguez, The Working Group For The Study Of The Immune Status In Health Care.   

Abstract

Pertussis is a re-emerging infection in countries with high infant immunization coverage. Healthcare workers (HCW) are exposed and can transmit the infection to especially-vulnerable patients. Therefore, pertussis vaccination of HCW is recommended. Between June 2008 and December 2010, 460 HCW from hospital and primary healthcare centers were recruited to determine susceptibility to pertussis. IgG antibodies against pertussis (anti-pertussis ab) were measured, using a routine technique that detects antibodies against pertussis including pertussis toxin (PT) and filamentous hemagglutinin (FHA). Positive results were confirmed with a more-specific technique that only assesses anti-PT IgG antibodies. The median age was 42 years (range, 21-65), 77.3% were female. 172 were nurses, 133 physicians, 60 other clinical workers and 95 non-clinical workers. None had received pertussis vaccination since childhood. The overall prevalence of anti-pertussis antibodies was 51.7%, (95% CI 47.1-56.4). Anti-PT antibodies were determined in the 220 HCW with positive anti-pertussis antibodies: 4 (1.8%) were negative and 33 (15%) had a high titer (≥ 45 IU/mL). No significant differences between the prevalence of anti-pertussis antibodies or anti-TP antibodies were found according to age, type of occupation or type of center. Our study confirms the need for vaccination of HCW because at least half are susceptible to pertussis. High anti-PT titers found in 15% of seropositive HCW showed that they had had recent contact with B. pertussis.

Entities:  

Keywords:  Pertussis; anti-pertussis toxin antibodies; health care workers; nosocomial pertussis outbreaks; pertussis antibodies; whooping cough

Mesh:

Substances:

Year:  2014        PMID: 25483549      PMCID: PMC4514259          DOI: 10.4161/hv.36167

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  25 in total

1.  Pertussis: adults as a source in healthcare settings.

Authors:  Natalie M Spearing; Robert L Horvath; Joseph G McCormack
Journal:  Med J Aust       Date:  2002-11-18       Impact factor: 7.738

2.  Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker.

Authors:  Kristina A Bryant; Kraig Humbaugh; Kyle Brothers; Judy Wright; F Brian Pascual; John Moran; Trudy V Murphy
Journal:  Infect Control Hosp Epidemiol       Date:  2006-05-24       Impact factor: 3.254

3.  Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France.

Authors:  Alexandra Ward; Jaime Caro; Laurence Bassinet; Bruno Housset; Judith A O'Brien; Nicole Guiso
Journal:  Infect Control Hosp Epidemiol       Date:  2005-03       Impact factor: 3.254

4.  Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.

Authors:  Angela Calugar; Ismael R Ortega-Sánchez; Tejpratap Tiwari; Liisa Oakes; Jeffrey A Jahre; Trudy V Murphy
Journal:  Clin Infect Dis       Date:  2006-02-15       Impact factor: 9.079

5.  Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.

Authors:  Futoshi Higa; Syusaku Haranaga; Masao Tateyama; Kenji Hibiya; Tsuyoshi Yamashiro; Miyuki Nakamatsu; Takeaki Tomoyose; Masayoshi Nagahama; Takayuki Okamura; Tomoko Owan; Tomoharu Kuda; Fukunori Kinjo; Jiro Fujita
Journal:  Jpn J Infect Dis       Date:  2008-09       Impact factor: 1.362

6.  Resource consumption in the infection control management of pertussis exposure among healthcare workers in pediatrics.

Authors:  Irini Daskalaki; Patricia Hennessey; Robin Hubler; Sarah S Long
Journal:  Infect Control Hosp Epidemiol       Date:  2007-03-16       Impact factor: 3.254

7.  Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.

Authors:  Maria-Rosa Sala-Farré; César Arias-Varela; Assumpta Recasens-Recasens; Maria Simó-Sanahuja; Carmen Muñoz-Almagro; Josefa Pérez-Jové
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-11-09       Impact factor: 1.731

8.  Hospital-acquired pertussis among newborns--Texas, 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-06-06       Impact factor: 17.586

9.  Pertussis outbreak on a neonatal unit: identification of a healthcare worker as the likely source.

Authors:  E M Alexander; S Travis; C Booms; A Kaiser; N K Fry; T G Harrison; B Ganpot; J L Klein
Journal:  J Hosp Infect       Date:  2008-04-03       Impact factor: 3.926

Review 10.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Authors:  N Guiso; G Berbers; N K Fry; Q He; M Riffelmann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

View more
  4 in total

Review 1.  Vaccination of healthcare workers: A review.

Authors:  Skerdi Haviari; Thomas Bénet; Mitra Saadatian-Elahi; Philippe André; Pierre Loulergue; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Immunization of Health-Care Providers: Necessity and Public Health Policies.

Authors:  Helena C Maltezou; Gregory A Poland
Journal:  Healthcare (Basel)       Date:  2016-08-01

3.  Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea.

Authors:  Won Suk Choi; Su Hyun Kim; Dae Won Park
Journal:  J Korean Med Sci       Date:  2018-11-19       Impact factor: 2.153

Review 4.  Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis.

Authors:  David J Weber; William A Rutala
Journal:  Infect Dis Clin North Am       Date:  2016-09       Impact factor: 5.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.